PLASMA AND CELLULAR ADRIAMYCIN CONCENTRATIONS IN PATIENTS WITH MYELOMA TREATED WITH 96-HOUR CONTINUOUS INFUSION

被引：45
|
作者：
SPETH, PAJ [1 ]
LINSSEN, PCM [1 ]
HOLDRINET, RSG [1 ]
HAANEN, C [1 ]
机构：
[1] ST RADBOUD UNIV HOSP,DEPT HEMATOL,NIJMEGEN,NETHERLANDS
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 06期
关键词：
D O I：
10.1038/clpt.1987.92
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：661 / 665
页数：5
相关论文
共 50 条
  • [1] ADRIAMYCIN CONCENTRATIONS IN PLASMA-CELLS OF PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH 96 HRS CONTINUOUS INFUSION
    SPETH, PAJ
    LINSSEN, PCM
    HOLDRINET, RSG
    HAANEN, C
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1986, 8 (02) : 164 - 164
  • [2] Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies
    Tetef, ML
    Synold, TW
    Chow, W
    Leong, L
    Margolin, K
    Morgan, R
    Raschko, J
    Shibata, S
    Somlo, G
    Yen, Y
    Groshen, S
    Johnson, K
    Lenz, HJ
    Gandara, D
    Doroshow, JH
    CLINICAL CANCER RESEARCH, 2001, 7 (06) : 1569 - 1576
  • [3] 96-hour infusion of paclitaxel in advanced bronchioloalveolar carcinoma
    Rachel Murphy
    Nature Clinical Practice Oncology, 2005, 2 (9): : 430 - 430
  • [4] PACLITAXEL BY 3-HOUR INFUSION FOLLOWED BY 96-HOUR INFUSION ON FAILURE IN PATIENTS WITH REFRACTORY MALIGNANT DISEASE
    CHANG, AY
    BOROS, L
    GARROW, G
    ASBURY, R
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 124 - 127
  • [5] Pharmacokinetics of paclitaxel administered as a 3-hour or 96-hour infusion
    Panday, VRN
    Huinink, WWT
    Vermorken, JB
    Rosing, H
    Koopman, FJ
    Swart, M
    Schellens, JHM
    Beijnen, JH
    PHARMACOLOGICAL RESEARCH, 1999, 40 (01) : 67 - 74
  • [6] Paclitaxel by 96-hour continuous infusion in combination with cisplatin: A phase I trial in patients with advanced lung cancer
    Georgiadis, MS
    Schuler, BS
    Brown, JE
    Kieffer, LV
    Steinberg, SM
    Wilson, WH
    Takimoto, CH
    Kelley, MJ
    Johnson, BE
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 735 - 743
  • [7] CELLULAR AND PLASMA ADRIAMYCIN CONCENTRATIONS IN LONG-TERM INFUSION THERAPY OF LEUKEMIA PATIENTS
    SPETH, PAJ
    LINSSEN, PCM
    BOEZEMAN, JBM
    WESSELS, HMC
    HAANEN, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (04) : 305 - 310
  • [8] Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma
    Ibrahim, NK
    Rahman, Z
    Valero, V
    Willey, J
    Theriault, RL
    Buzdar, AU
    Murray, JL
    Bast, R
    Hortobagyi, GN
    CANCER, 1999, 86 (07) : 1251 - 1257
  • [9] 10-HOUR CONTINUOUS INFUSION OF ADRIAMYCIN
    GERCOVICH, FG
    PRAGA, C
    BERETTA, G
    MORGENFELD, M
    MUCHNIK, J
    PESCE, R
    HO, DHW
    BENJAMIN, RS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 372 - 372
  • [10] No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule
    Younes, A
    Ayoub, JP
    Hagemeister, FB
    McLaughlin, P
    Sarris, A
    Rodriguez, MA
    Swan, F
    Romaguera, JE
    Martin, J
    Cabanillas, F
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 543 - 548
12345